MIM
AMTX icon

MetLife Investment Management’s Aemetis AMTX Stock Holding History

MetLife Investment Management’s Portfolio AMTX Stock Details AMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,203
Closed -$24.6K – 2791
2022
Q4 		$24.6K Sell
6,203
-9,443
-60% -$53.6K ﹤0.01% 2808
2022
Q3 		$95.8K Buy
+15,646
New +$119K ﹤0.01% 2692
2022
Q2 		– Sell
-15,153
Closed -$192K – 2860
2022
Q1 		$192K Buy
15,153
+5,501
+57% +$60.6K ﹤0.01% 2376
2021
Q4 		$119K Hold
9,652
– – ﹤0.01% 2343
2021
Q3 		$176K Buy
+9,652
New +$107K ﹤0.01% 2174

Other funds holding AMTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return

MetLife Investment Management's AMTX Position: Q1 2023 in Review

MetLife Investment Management sold out of Aemetis (AMTX) in Q1 2023, closing a stake of 6,203 shares — an estimated $24.6K sold.

MetLife Investment Management first reported a position in AMTX in Q3 2021 and held it in 5 quarters. The position peaked at $192K in Q1 2022. 77 funds tracked by Wall St. Rank hold AMTX as of Q1 2023.

  • MetLife Investment Management reported no remaining Aemetis position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 6,203 Aemetis shares in Q1 2023, an estimated $24.6K.
  • MetLife Investment Management first reported a position in Aemetis in Q3 2021 and held it in 5 quarters.
  • MetLife Investment Management's Aemetis position peaked at $192K in Q1 2022.
  • 77 funds tracked by Wall St. Rank held Aemetis as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.